Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) showed a trend towards higher levels of serum leptin compared to other patients, but this trend also did not reach statistical significance ( Figure A1 B). 3.2.
← all excerpts
Diagnostic and Prognostic Value of Serum Leptin in Critically Ill Patients with Acute versus Acute-on-Chronic Liver Failure
2
—
—
The sentences
Serum leptin tends to be lower in higher grade ACLF, although this difference did not reach statistical significance ( Figure 1 B).